Litcius/Paper detail

Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Immunoglobulin D Multiple Myeloma

Wei Chen, Ying Wang, Kunming Qi, Ming Shi, Jiang Cao, Rahul S. Bhansali, Xue Wang, Yang Liu, Hujun Li, Huan-Xin Zhang, Zhiling Yan, Wei Sang, Hai Cheng, Feng Zhu, Haiying Sun, Depeng Li, Guangjun Jing, Junnian Zheng, Zhenyu Li, Kailin Xu

2020Transplantation and Cellular Therapy11 citationsDOI

Topics & Concepts

MedicineImmunoglobulin DChimeric antigen receptorMinimal residual diseaseMultiple myelomaCytokine release syndromeAntigenRefractory (planetary science)Internal medicineBone marrowImmunologyOncologyAntibodyT cellB cellGastroenterologyImmune systemPhysicsAstrobiologyCAR-T cell therapy researchMultiple Myeloma Research and TreatmentsViral Infectious Diseases and Gene Expression in Insects
Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Immunoglobulin D Multiple Myeloma | Litcius